"Fliksotid": aʻo no ka hoʻohana, nāʻana. lāʻau analogues

Nei anei oe i ka mea a ka lāʻau "Fliksotid" mea? Na Ke Kumu no ka hoʻohana ana i ka lāʻau, kona nāʻikepili, haku mele 'ana,ʻaoʻao' ole a me ke kalaʻana aku palapala e e ho'ākāka 'ia ma ka au mamuli lalo nei. Eia hou, e hai aku mākou oe e pili ana ina paha he mau contraindications o ka haawina i e ia i loko o ka hanana o ka overdose, naʻe ka mea, he pharmacological waiwai, a no laila, ma luna o.

I ka haku mele 'ana a me ke ano o ke kalaʻana aku lāʻau

Ma ka palapala e kuai i ka lāʻau "Fliksotid" kauoha no ka hoʻohana a pono e pili ana i ka hale? Currently, ka lāʻau ua wale kuai ma ke ano o ka inhalation aerosol. I ka papa kuhikuhiEʻeleu waiwai ka fluticasone propionate mikroionizirovanny. lāʻau i nā mea he hou ke keʻena me tetrafluoroethane.

Hua metala medicament inhaler i loaʻa i ka concave lalo, a me ka metering manaʻo i hoʻolako pono me ka sprayer. Loko o ka ipu o ka wehe ana o keʻokeʻo pahaʻaneʻane keʻokeʻo. Me ke kuai ana o na mea paahana, eʻoiaʻiʻo nō ia e lohe i ka ili o ka inhaler. Kona kiwikā pono ole i hiki mā.

Kind o aerosolized lāʻau

Ke kaumaha ma muli o ka loa i ka a me ka hana 'Oponopono mea i loaʻa i loko o ka wehe, eia ekolu ano poe ma ka medicament. Lākou mau inoa heluhelu ia penei: ". Flixotide Evohaler" "Flixotide hui kūkā pū paha", "Fliksotid Nebula" a me ka

Ke pharmacological ano o ka lāʻau

He aha mea i ka lāʻau "Fliksotid"? Na Ke Kumu no ka hoʻohana hākālia nō i konaʻeleu hehee ai pili ia i ka hui GCS kūloko 'ole. Wā lawelawe ma ka inhalation kaʻeleu waiwai produces haʻi antiallergic a me ka antiinflammatory 'ole. E like me ka hopena, markedly hoemiia ka oolea o symptoms, e like me ke alapine (frequency) o exacerbations pathologies pu ma ka airway iaʻi (e laʻa me, maʻi bronchitis, asthma a me ka emphysema).

Na ke hoʻohana rula o ka lāʻau (aerosol)

Pehea ke ano o ka lāʻau "Fliksotid Nebula" a me nā ano o keia k? Ke kumu o waiwai e inhibit kia ke kelepona hele ka hoʻonuiʻana, macrophages, eosinophils, neutrophils a me lymphocytes e like me ho'ēmi i kā ka iecaianoaaiiuo, a hookuu uao o ka li nui , a me ka biologically hana waiwai (e like me histamine, prostaglandin, leukotriene, he cytokine).

I ka maʻi obstructive pulmonary maʻi kiʻekiʻe hopenaʻoi loa hopena o keia k ma luna o ka hana hui, o ka naehana'ōnaehana, kūpono i ka maʻi symptoms mea,ʻaʻole i haʻi, ua hoemiia ke alapine (frequency) a me ka oolea o exacerbations, a me kekahi mea i pono, e lawe keu GCS papa. E like me ka hopena, ka mea maoli i ka pono o ke ola o ka hoʻomanawanui.

Systemic hana o ka lāʻau hōʻike minimally. Ma keia manao, ma ka pākōlea nā māhele, ka mea, uaʻaneʻane ole hopena ma luna o ka hypothalamic-pituitary-adrenal iho (axis).

Medicament "Fliksotid", a analogues e kapaʻia ma lalo iho nei e, koke e hooponopono i ka hoʻomanawanui i ka pane i bronchodilators, hoemi i ke alapine (frequency) o ko lākou hoʻohana.

Ka pākōlea kanawai ma hope o ke noi ana o ka aerosol inhaler hoʻomaka i loko o nā lā, a hiki i ka i kā mākou no elua pule a oi. Ka hopena ua waiho no kekahi mau lā ma hope o discontinuation o ka lāʻau.

Nā pharmacokinetics o aerosolized Agena

Ma hope o aerosol "Fliksotid" Ua ua hoʻohana no kona Manao iho la ia mea, kona loa bioavailability o kaʻeleu waiwai o 8-11%.

Systemic lāʻau omo ia lŘlŘ kuhikuhi ma na maʻiʻaʻai. Ma ke ala, initially ke omo ua lawe mai koke, a laila, 'aʻole hoʻi ia. Iloko o ke kaʻina hana, hapa o ana ka wehe hiki ke ale e ka hoʻomanawanui. Eia naʻe, kona systemic waiū mea ka palena haʻahaʻa no ka mea, o ka mea ilihune solubility o ka lāʻau i loko o ka wai, e like me ka pono me nui pūnao me ka mea hala ae ma ke akepaʻa.

Wai koko kumuʻiʻo ka paa ana o ka lāʻau ma ka moderately kiʻekiʻe a me ka mea e pili ana i 91%. ʻeleu lāʻau ua metabolized ma ke akepaʻa hehee ai ke komo pū CYP3A4. E like me ka hopena, AEeOEXAaI metabolites i hana.

Medicament "Fliksotid" i ka hapanui 'oluʻolu nāʻana, i ke' ano kiʻekiʻe wai kokoʻae. I loko o kona hapa-ola mea e pili ana i 8 hola. Ia auoiaea ia me metabolites i loko o ka mimi.

Nāʻikepili no ka hoʻohana o aerosolʻano

I kekahi manawa, ma laila i "Fliksotid" ia waiʻona? Na Ke Kumu ma ka noi papa hoike i ke ka lapaʻauʻia i hoakaka ia no ka iapaau ana o nā mea maʻi e ae aku, mai asthma, e kahe ana i loko o ke kaumaha, a me lōpū palapala. Nō hoʻi, ke medicament ua hoʻohana 'ia no ka pale ho'āhewa wale' ia e loaa ana systemic corticosteroids.

Eia kekahi, o ka medicament ua hōʻike ma nā mea maʻi me ka maʻi akemāmā maʻi. E hoʻohana i mea e ho'ēmi i bronchial iaʻi, e like me ka hoʻomaikaʻi i ka hoʻokomo ea o ka ÷ naehana hanu nā loko.

Contraindications i ka hoʻohana 'ana o ka aerosolʻano

Ma lalo o kekahi kumu i loko o kekahi hihia hiki ole ke hoʻohana inhaler 'Flixotide'? Contraindications i na kēia kumumea:

• hoʻomanawanui hypersensitivity i kekahi ke keʻena o ka medicament;
• huʻi bronchospasm;
• asthmatic kūlana haʻahaʻa (e like me ka mea mua);
• mai ai i 1 makahiki.

It E e kaulana no hoi i keia k mea i kupono i ka hana no ke kokua ana o asthma ho'āhewa wale.

Akahele ana o ka lāʻau

lāʻau "Fliksotid" loa akahele kohoia Under ka noho ana? Reviews kauka e olelo aku i ka mea kökua ka pono e e hoʻohana ma lalo o kekahi lāʻau 'pololei akamai ma ka glaucoma, ake cirrhosis, pulmonary tuberculosis, hypothyroidism, hāpai keiki, systemic nā mea palahēhē (mea koʻohune, fungal, parasitic ole mea hoʻomaʻi) a me ka lactation a me ka osteoporosis.

Uluwehi O "Fliksotid" inhalation: ke aʻo

Ke kaumaha ma muli o ka 'ano o ka huina hoonui, kona' ae a me ka laʻau heluna i ĸokoĸa ana nä pane nunui. No ka laʻana, e kū ai i ka makemake kanawai,ʻehu 'Flixotide hui kūkā pū paha "E ke hoʻohana mau, a hiki i ke kala.

Ka lōʻihi like 'ole o ka Inc, a me ka e pono ai ke mahele lāʻau o ka lāʻau e hoakaka wale i ke kauka, e lawe i ka mooolelo o ka hoʻomanawanui ka ana, a me ka nohona ma lapaʻau kiʻi. No nā mākua, i ka laʻau heluna mea 100-1000 mg 2 manawa i ka lā. I ka hoʻohana 'ana i ka lāʻau' hoomaka i ka palena iki puke i paka i ka pākōlea hopena. Inā pono, hiki e hoonuiia ka huina o ka lukuʻia ai '. ʻO kā mākou mahele lāʻau E ole mamua o 2000 micrograms.

Medicament "Fliksotid" no na keiki mai ka 4 makahiki o ka makahiki i hana eha iaʻi mai bronchial asthma, ua häʻawi mai i ka nui o 50-100 mg palua ia i ka lā. Inā pono, keia laʻau heluna ua i nā mahuahua mai i 400 micrograms no ka lā. Like no nā mākua me ka maʻi akemāmā maʻi, ka mea ana i haawi 500 mg o ka lāʻau palua ia i ka lā.

Pehea e hoʻohana i ka lāʻau "Flixotide Evohaler"?

Keia mea paahana E e hoʻohana mau. ka mea, ua pono i kaʻehu kekahi mau manawa ma mua ana o ka lapaʻauʻia no kaʻaʻahu mahele lāʻau. Nō hoʻi, ke slurry mea pono e hoohaalulu ai i ka mole. I kaʻawa i ka aerosol i ka hoʻomanawanui ua koi 'ia e ke kali hoʻi koʻu hanu. Ka waha'ōlelo E e ua holoiʻia ma ka liʻiliʻi koke i ka pule.

Pehea e hoʻohana i ka paipai dala o ka lapaʻauʻia "Fliksotid"? Nā māhele o ka lāʻau 'pōpilikia like penei: hoʻokahi-aku i dala o ka lāʻau e like me ka mau sputtering.

Ma bronchial asthma nā mākua koho 100-1000 micrograms oʻeleu waiwai palua ia i ka lā. Ke hoʻohana no ka lapaʻauʻia e e hoʻomaka 'ana me ka haʻahaʻa ka hoʻokō nā māhele, vposlestvii, ina o ka pono aicieeaao, ka mea hiki ke mahuahua. ʻO kā mākou dala o ka lāʻau pono e 2000 micrograms.

Pehea e hana i nā keiki, e hoʻohana i kaʻehu "Fliksotid"? Inhalation keiki no makahiki eha me keia maʻi e like me asthma, e ia i loko o ka nui o 50-100 mg palua ia i ka lā. Inā pono, o ka mahele lāʻau hiki ke i nā mahuahua. ʻO kā mākou dala o ka hokii, a me ka lāʻau no nā keiki ma luna o eha makahiki o ka makahiki, he 400 mg.

Nā mākua me ka maʻi obstructive pulmonary maʻi lāʻau koho 500 micrograms palua kela la i keia. Inā ma hope o 3-6 mahina ma hope o he lālā o ka Inc, e hoʻoikaika 'ana, aʻaʻole hoʻi i mālama, ka mea i pono, e hoʻololi i ka iapaau ana regimen.

Inā he keiki ma waena o nā makahiki o 1 a me 4 makahiki o ka makahiki diagnosed me ka asthma, ka mea, ua hoakaka 100 mg o ka lāʻau palua ia i ka lā. Ma keia hihia, inhalation ua? Aeiiaiaoaony e hoʻohana i ka pediatric Spicer me ka hoihoi 'inoa "Bebihaler".

Aerosol "Fliksotid Nebula": kauoha no ka hoʻohana

Kēia medicament hiki ke hoʻohana no ka moʻolelo (me ka waha'ōlelo) ole nasal (mua Approach) inhalation. Nō hoʻi, i ka lāʻau ua pinepine i hoʻokohu 'like me ka aerosol mokulele hēkī nebulizer. He loa kupono e hoʻohana ultrasonic nä manaʻo.

Inā makemake malama aku hoʻoponopono o ka Luna a me ka hooponopono ana o liʻiliʻi nā māhele o ka medicament ma mua o ke inhalation kaʻina hana e waiho i loko o ka dilute pāʻoihana o ka paʻakai koloriside.

Nā mākua a me nā adolescents no 16 makahiki o ka lāʻau lawelawe i loko o ka nui o ka 0.5-2 mg palua kela la i keia. ʻO kā mākou laʻau heluna E e ukali no ka hebedoma hope o ka hoouka ana o asthma, a laila, i nā emi ia.

Inā i ka hopena o ka hoʻomaikaʻiʻana i ke ano, a e ka hoʻololi mai ka lāʻau "Fliksotid Nebula", a ke aʻo mau mai i nāʻano o ka lāʻau.

Keiki mai ka 4 a hiki i 16 makahiki medicament lawelawe i loko o ka nui o ka 1 mg palua i ka lā.

hihia o ka overdose

I Ina o overdose, i ka hoʻomanawanui i 'ike i? Aiaiiuie suppression o ka hana o ka hypothalamic-pituitary-adrenal'ōnaehana, nui suppression o adrenocortical haʻawina, huʻi adrenal ulia i loko o na keiki i loaa i kekahi mahele lāʻau o ka 1000 mcg no ka lā, a ma luna.

Eia hou, nā mea maʻi i mau naau ike, eia spasms a me hypoglycaemia. Ua E hoi e kaulana i huʻi adrenal ulia ana e hoʻomōhala ana i loko o ke kāʻei kua o nā kūlana e like me loa trauma,ʻoki kino, maʻiʻaʻai a me ke alo aku o ka pahi emi ma ka lāʻau laʻau heluna.

ʻaoʻao waiwai

E hiki anei i ka hopena maikaʻi 'ole ma ka ola o ka hoʻomanawanui? Eaia "Fliksotid" ia waiʻona? ʻaoʻao 'ole i kokoke a pau' inikua manaʻo. A me ka hōʻike o ana lapaau mea i koe.

• 'ōnaehana paleʻea'ōnaehana: ili reactions aie i ka hypersensitivity, angioedema (oropharynx a me ka maka), kāna hana o ka naehana'ōnaehana (dyspnea a bronchospasm), anaphylactic kŰia.
• A parasitic infectious maʻi: candidiasis o ka waha a me ka puʻu, a me ka thrush. Me na abnormalities ua waiho e holoiʻia ia i ka puʻu, a me ka waha me ka papu ka wai. Ua hiki ke hoʻohana i antifungals kūloko hana. Loa, he pono oleʻaoʻao 'ole e hahai ana i ka hoʻohana' ana o ka aerosol mea pneumonia, akā, wale i loko o nā mea maʻi me ka COPD.
• Pūnao: hyperglycemia.
• Endocrine'ōnaehana: Cushing ka maʻi pale, kaumaha ana o ka adrenal cortex, hoemiia mineralization o ka iwi'aʻaʻa, ulu retardation, cataracts, glaucoma.
• Ko mākou hopohopo'ōnaehana: ka iini, 'ano' kāna hana, a me ka hiamoe, irritability a me ka hyperactivity (oi loa aku hoi i na keiki).
• Subcutaneous momona: i pēpē.
• Naehana'ōnaehana: hoarseness (paipai koke ma hope o ke kaʻina hana, a gargle kou waha me ka wai), paradoxical bronchospasm.

Cautions ka wā hoʻohana 'ana i ka lāʻau'

Ho opa ao ana i ka hoʻohana 'ana i ka lāʻau' aʻole pono.

E pakahi aku la ia manao i loko o ka iapaau ana o ana corticosteroids i loko o nā mea maʻi me ka AEeOEXAaI aʻeleu ano o ka tuberculosis.

Ma hope mai o ka manawa i oleloia ai o ka lāʻau i ke kauka pono e kaha i ka hoʻomanawanui ike pehea e hoʻohana i ka inhaler. Iloko o ke kaʻina hana, ia mea pono i ka hōʻoia 'ana i ka ka ho'ēmiʻana o ka lāʻau i loko o ka hana i wahi ma ka hoʻononiakahi me ka hanu. Wale ma keia aoao o ka hoʻomanawanui nō e hiki ke hōʻoia 'e pono ai ke haawi i ka hana hehee ai a hiki i ka ia maʻiʻaʻai.

? Aeiiaiaiaaia e noke kanaka hoʻoponopono i nāʻano o ka ulu ana o kahi mau keiki liilii, ka poe e hookipa ana corticosteroids no ka lōʻihi manawa.

A lohe o laila 'o ia i ka hoʻomanawanui mai ka loaa ana systemic corticosteroids no inhalation Inc e worsen allergic maʻi (e laʻa me, allergic rhinitis ole eczema) mea i mua uhi pū systemic lapaʻauʻia. Ma na hoopii, symptomatic Inc me antihistamines a topical lapaʻauʻia.

Like loa ana lapaʻauʻia i loko o aerosol pahu waihona me ka, e e hoemiia ka pākōlea hopena, i ka wa anuanuʻehu.

I ka lā, loaʻa nō pohihihi keia hoike i ka hoomanawanui, ua e noʻonoʻo ka hoʻohana 'ana i ke koʻi lipi, piʻina ma loko o ke koko monakō koko pae. Kēia E mau e hoʻomanaʻo kauka ka wā e ho'ākākaʻia ma ka lāʻau a hiki i nā mea maʻi i mimikō.

Ke kanawai o kaʻeleu waiwai i loko o kekahi kanaka i ka hana, e hana i ka mīkini a me ka hana ana me machines i kauoha kiʻekiʻe lehulehu,ʻaʻole paha.

Analogs medicament

He aha lāʻau kūʻai, ina uaʻaʻole hiki ke kūʻai i ka lāʻau "Fliksotid" ke hoʻomanawanui? Analogs o ka mea paahana i kekahi o ia waiwai. Akā, ma mua ana ia lakou, e waiho aku ia oe heluhelu i ka lelo kauoha, e like me ke kukakuka pu ana me ka hoʻomalu.

Currently, ka mea kēia mea like o ka lapaʻauʻia: ". Valium" ai ' "Kutiveyt", "Nazarel" "Flixonase" "Fluticasone" a me ka It E e hoʻomaopopo i ke kumu kuai o kēia mau ai 'i iaʻokoʻa ma mua o ka mua. Ma ke ala, i ka aerosol "Fliksotid" oe ke kuai i 570 (50 .mu.g, 120 nā māhele), 840 (125 mg, 60 nā māhele) ole 140 (250 .mu.g, 60 nā māhele) Lūkini rubles.

Reviews o inhalants

He aha hana kauka a me nā mea maʻi e pili ana i ka lāʻau 'Flixotide'? Reviews o keia hale, he mauʻano nui maikaʻi. O ke kumu ho kuhikuhi ana i ka mea i ka aerosolized medicament i kŘpa a kiʻekiʻe ka hoʻokōʻana. Ua me ka nui loa ho'ēmi i kā ke alapine (frequency) o ka ho'āhewa wale 'ana o nā mea maʻi me ka asthma, a me iaono? Ienoai bronchial patency i loko o ka poʻe i hana eha iaʻi mai ka maʻi akemāmā maʻi.

Like no ka hopena maikaʻi hōʻike manaʻo, e like me ka rula, e hele mai, mai nā mea maʻi ka lapaʻauʻia incorrectly paha i hoakaka ia e ke kauka nana i hoʻohana. No laila, e kū ai i ka loa maikaʻi hualoaʻa ma mua ka hoʻohana 'ana i ka lāʻau', like hoʻi me kona counterparts, ka mea, ua? Aeiiaiaoaony e hoʻopaʻa haʻawina ma ka au mamuli o ka puni iho la ka olelo ao no ka hoʻohana. Eia hoʻi, ia mea mau Kuleana e ike i ke kauka, ka mea, i ka mea, a me ka pono Meu keia mea paahana, me ka nānā 'ia ma ka hopena o ka' inikua ninaninau.

Pehea e hoahu aerosol hoʻomanaʻo?

Ana aerosol aeiiaiaiaaia e pepehi ai i ka pouli, kahi o ka mahana, aole ia i oi aku mamua o 25 degere. Ke holopapa ola o ka lāʻau mea pono mau makahiki. Ma hope iho o kēia wā ka mea, ua hiki ole i ka hana.